James Ruhlmann, MD
Internal Medicine · Hutchinson, KSNPI 1316919426
Payments from drug & device makers
Across 1,561 payments — averaging $1776.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Emergent Biosolutions Inc.$1.2M
- Genentech, Inc.$649K
- Takeda Pharmaceuticals U.S.A., Inc.$362K
- Novartis$168K
- AstraZeneca$162K
- Regeneron$67K
- plus $208K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Emergent Biosolutions Inc. | 1,193 | $1,158,017 |
| Genentech, Inc. | 62 | $649,041 |
| Takeda Pharmaceuticals U.S.A., Inc. | 91 | $361,918 |
| Novartis | 13 | $167,524 |
| AstraZeneca | 4 | $161,937 |
| Regeneron | 16 | $66,566 |
| Astrazeneca UK Limited | 3 | $63,366 |
| Esperion Therapeutics, Inc. | 74 | $46,060 |
| Sanofi US Services Inc. | 4 | $45,921 |
| Alnylam Pharmaceuticals Inc. | 4 | $27,805 |
| BD | 1 | $12,075 |
| Bayer | 6 | $8,675 |
| Amgen | 3 | $2,901 |
| Novo Nordisk | 59 | $818 |
| AbbVie | 8 | $141 |
| Pfizer | 6 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $72 |
| Abbott | 3 | $41 |
| Exact Sciences | 2 | $32 |
| Insulet Corporation | 1 | $25 |
| Abiomed | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,773,103 in reported general payments places this provider in the 95th percentile of 705 internal medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Hutchinson
- Mark YackleyHutchinson$10K
- Michael GreenHutchinson$7K
- Sara PatryHutchinson$5K
- Martin KankamLeavenworth$63.4M
- Mark HamblinKansas City$5.2M
- Katherine WillinghamTopeka$4.8M
- Raed Al RajabiWestwood$4.5M
- Leslie SpikesKansas City$4.5M
- Michael CoxTopeka$3.4M
- Scott TeeterTopeka$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.